Skip to main content

Dupilumab for atopic dermatitis - a biologic that actually works for severe eczema.

For children and adults with moderate-to-severe atopic dermatitis that steroids and standard treatments are not controlling. A consultant paediatric allergist or dermatologist, prescription and monitoring of dupilumab (Dupixent), and honest talk on cost.

A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Indicative pricing

What private dupilumab for eczema costs in the UK.

In short

Private dupilumab: £1,000–£1,500 per month, plus 3-monthly reviews.

ItemIndicative range
Consultation and eczema scoring£250–£450
Baseline bloods and TB screen£150–£300
Dupilumab drug cost (per month, private)£1,000–£1,500
Nurse-led injection training£150–£250
Follow-up review (3-monthly)£180–£350
JAK inhibitor (upadacitinib / abrocitinib) monthly£1,500–£2,200
Written eczema planIncluded

The problem

A biologic prescribed and monitored properly, with an honest price conversation.

  • A licensed biologic that changes lives

    Dupilumab is licensed from 6 months of age for moderate-to-severe atopic dermatitis and works for most patients.

  • Consultant-led prescribing and monitoring

    Real 3-monthly reviews, eczema scoring, and clear stopping rules.

  • Honest on private cost

    Dupilumab is expensive. We will always tell you if you meet NHS access criteria and are better going that way.

When it helps

When dupilumab for eczema is the right step.

  • Moderate-to-severe eczema uncontrolled on topicals

    EASI or IGA scores that meet biologic criteria, poor sleep, school or work impact.

  • Failed or intolerant of systemic immunosuppressants

    Methotrexate, ciclosporin or azathioprine that has not worked or caused side effects.

  • Steroid overuse in a young child

    A family reaching for potent steroids far too often.

  • Coexisting asthma or nasal polyps

    Dupilumab is licensed across atopic conditions - it helps both.

  • Adolescents heading into exams

    Poor sleep from itch is a real driver of low mood and grades.

  • Adults with head-and-neck eczema

    Often the hardest to treat with topicals alone.

  • Not for mild eczema

    Optimise emollients, steroids and triggers first.

  • Red flag: airway swelling, breathlessness or collapse

    Adrenaline first, 999 second. Every family with a diagnosed allergy needs to be clear on this.

Options

Biologics and small molecules for severe eczema.

  • Dupilumab (Dupixent)

    Anti-IL-4Rα biologic, fortnightly injection, licensed from 6 months.

  • Tralokinumab (Adtralza)

    Anti-IL-13 biologic for adults with moderate-to-severe eczema.

  • Lebrikizumab (Ebglyss)

    Newer anti-IL-13 biologic, monthly maintenance dosing.

  • Upadacitinib (Rinvoq)

    Oral JAK inhibitor - fast-acting, with monitoring requirements.

  • Abrocitinib (Cibinqo)

    Oral JAK inhibitor for adults with severe eczema.

  • Baricitinib (Olumiant)

    Oral JAK inhibitor for selected adult cases.

  • Methotrexate, ciclosporin, azathioprine

    Traditional systemic options - still used, cheaper, more side effects.

  • Written eczema plan + emollient routine

    Underneath any biologic - the basics still matter.

Safety and recovery

What to expect - honestly.

  • Conjunctivitis

    Common on dupilumab - usually mild and treatable, occasionally needs ophthalmology.

  • Injection-site reactions

    Redness and soreness at the site, usually settle after the first few doses.

  • Head-and-neck dermatitis

    A recognised paradoxical reaction in a small percentage of patients.

  • Vaccine considerations

    Live vaccines are usually avoided while on dupilumab - plan around it.

  • No routine blood monitoring on dupilumab

    Unlike JAK inhibitors, dupilumab does not need regular bloods.

  • JAK inhibitors need bloods and screening

    FBC, lipids, TB, hep B and C, plus regular monitoring.

  • Pregnancy

    Dupilumab data in pregnancy are limited but reassuring; discuss with your consultant.

  • Cost and stopping rules

    Plans need to include realistic stopping criteria if the drug is not working.

  • Red flag: airway swelling, breathlessness or collapse

    Adrenaline first, 999 second. Every family with a diagnosed allergy needs to be clear on this.

Your notes

Your report in four parts.

A UK consultant reviewing notes
  1. Header

    Diagnosis and severity

    EASI, IGA, DLQI or CDLQI scores and previous treatments tried.

  2. Technique

    Loading and maintenance dosing

    Weight-based loading and fortnightly maintenance schedule.

  3. Findings

    Response at 3 and 6 months

    How much of the disease has cleared and quality-of-life change.

  4. Impression

    Plan and stopping rules

    Read this first: whether to continue, adjust or step down.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

Paediatric allergy is available on the NHS but 6–18 months waits are typical for a first specialist appointment; it is usually covered by private insurers when medically indicated.

Frequently asked

Everything we get asked about dupilumab for eczema.

  • When is dupilumab actually worth prescribing?

    When moderate-to-severe atopic dermatitis is uncontrolled by topical steroids, calcineurin inhibitors and a solid emollient routine, or when a patient has failed or cannot tolerate methotrexate or ciclosporin. It is not for mild eczema.

  • What does starting dupilumab involve?

    A consultant assessment with EASI and IGA scoring, baseline bloods and TB screen, then a loading dose followed by fortnightly injections. Most children can be taught to self-inject or a parent can do it. Reviews at 3 and 6 months.

  • How much does dupilumab cost privately in the UK?

    Roughly £1,000–£1,500 per month for the drug at private prices, plus £250–£450 for the initial consultation and £180–£350 for each 3-monthly review. Some patients get discounted access through hospital pharmacies.

  • Is dupilumab available on the NHS?

    Yes, following NICE guidance for moderate-to-severe atopic dermatitis in adults and children (down to 6 months). Access varies by trust and eczema score.

  • How quickly does dupilumab work?

    Most patients see meaningful improvement within 4 to 12 weeks. If there is no useful response by 16 weeks, the drug is usually stopped.

  • Will my child need to stay on it forever?

    Some patients need continuous treatment; others can extend the interval or come off after a sustained clear period. We build a stopping-rule plan into the prescription.

Related treatments

Looking for something else?